Amercican Urologicall Assn Guidancw on Acewwning

The American Urological Association (AUA) and the AUA Foundation believe that early detection of and risk assessment for prostate cancer should be offered to asymptomatic men 40 years of age or older who have a life expectancy of at least 10 years. Men who wish to be screened should have both a prostate-specific antigen (PSA) test and a digital rectal exam (DRE). This program will provide information to learn more about the pros and cons of prostate screening. Program Objectives: 1 Discuss prostate screening and common prostate conditions 2 Identify current AUA recommendations for prostate screening-PSA and DRE tests 3 Describe the role of the following factors in prostate screening: free an d total PSA patient age PSA velocity PSA density family history ethnicity prior biopsy history the impact of other health conditions on prostate screening 4 Explain the prostate biopsy procedure 5 Identify questions to ask health care providers regarding individual prostate screening benefits and risks Participants in the live program will have an opportunity to present questions to the speaker panelat the conclusion of the program. This forum will be recorded for future online viewing. Meeting Organizer/Moderator: Stephanie Chisolm, PhD, AUA Foundation Mark your calendar for future Webinars in the series: Living with Prostatitis Tuesday, September 15, 2009 8-9:30 p.m. ET Featured Medical Expert: Anthony Schaeffer, MD, Feinberg School of Medicine,Northwestern University, Chicago, IL Enlarged Prostate or Benign Prostatic Hyperplasia Tuesday, September 22, 2009 8-9:30 p.m. ET Featured Medical Expert: Claus Roehrborn, MD, Department Head of the University of Texas Southwestern Medical Center in Dallas, TX, and member of the AUA Guidelines Panel for Benign Prostatic Hyperplasia